Avanir To Pay $108M Over Nuedexta Drug Kickback Scheme
By Hailey Konnath · September 26, 2019, 9:26 PM EDT
Drugmaker Avanir Pharmaceuticals has agreed to shell out more than $108 million in criminal penalties, forfeiture and civil damages for an alleged kickback scheme that involved the company paying physicians to...
To view the full article, register now.